Real-world retreatment of HCV-infected patients with prior failure to direct acting antiviral therapy using sofosbuvir, velpatasvir and voxilaprevir

被引：0
|
作者：
Smith, David A. [1 ]
Bradshaw, Daniel [2 ]
Mbisa, Jean [2 ]
Manso, Carmen [2 ]
Bibby, David [2 ]
Singer, Josh [3 ]
Thomson, Emma [3 ]
Filipe, Anna da Silva [3 ]
Aranday-Cortes, Elihu [3 ]
Ansari, Azim [1 ]
Brown, Anthony [1 ]
Hudson, Emma [1 ]
Benselin, Jennifer [4 ,5 ]
Healy, Brendan [6 ]
Troke, Phil [7 ]
Mclauchlan, John [3 ]
Barnes, Eleanor [1 ]
Irving, William [4 ,5 ]
机构：
[1] Univ Oxford, Peter Medawar Bldg Pathogen Res, Nuffield Dept Med, Oxford, England
[2] Publ Hlth England, Natl Infect Serv, London, England
[3] Univ Glasgow, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland
[4] Univ Nottingham, Nottingham, England
[5] Nottingham Univ Hosp NHS Trust, Nottingham, England
[6] Univ Hosp Wales, Publ Hlth Wales, Microbiol Cardiff, Cardiff, Wales
[7] Gilead Sci Ltd, London, England
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU402
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [21] A Randomized, Controlled, Phase 3 Trial of Sofosbuvir/Velpatasvir/Voxilaprevir or Sofosbuvir/Velpatasvir for 12 Weeks in Direct Acting Antiviral-Experienced Patients with Genotype 1-6 HCV Infection: The POLARIS-4 Study
    Zeuzem, Stefan
    Flamm, Steven L.
    Tong, Myron J.
    Vierling, John M.
    Pianko, Stephen
    Buggisch, Peter
    de Ledinghen, Victor
    Hyland, Robert H.
    Wu, Xiaoru
    Svarovskaia, Evguenia S.
    Stamm, Luisa M.
    Brainard, Diana M.
    Subramanian, Mani
    McHutchison, John G.
    Verna, Elizabeth C.
    Bansal, Meena B.
    Landis, Charles S.
    Strasser, Simone I.
    Cooper, Curtis
    Kowdley, Kris V.
    HEPATOLOGY, 2016, 64 : 59A - 59A
  • [22] Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan
    Liu, Chen-Hua
    Su, Tung-Hung
    Liu, Chun-Jen
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (12) : 1871 - 1875
  • [23] Effectiveness of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C virus infection and virologic failure to direct-acting antivirals
    Ruiz-Boy, Sonia
    Rodriguez-Reyes, Montserrat
    Sotoca-Momblona, Jose Miguel
    MEDICINA CLINICA, 2021, 157 (02): : 85 - 86
  • [24] Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients
    Lattanzi, Barbara
    Baroncelli, Silvia
    De Santis, Adriano
    Galluzzo, Clementina Maria
    Mennini, Gianluca
    Michelini, Zuleika
    Lupo, Marinella
    Corradini, Stefano Ginanni
    Rossi, Massimo
    Palmisano, Lucia
    Merli, Manuela
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1146 - 1155
  • [25] Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto Networks
    Degasperi, E.
    Spinetti, A.
    Lombardi, A.
    Landonio, S.
    Scotton, P.
    Pasulo, L.
    Carlotto, A.
    Giorgini, A.
    Pozzoni, P.
    Angeli, P.
    Carrara, M.
    Puoti, M.
    Gatti, F.
    Carolo, G.
    Vinci, M.
    Zoncada, A.
    Bonfanti, P.
    Aghemo, A.
    Soria, A.
    Centenaro, R.
    Maggiolo, F.
    Russo, F. P.
    Rovere, P.
    Piovesan, S.
    Capra, F.
    Viviani, F.
    Morini, L.
    Soffredini, R.
    Carriero, C.
    Paolucci, S.
    Noventa, F.
    Alberti, A.
    Lampertico, P.
    Fagiuoli, S.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E15 - E15
  • [26] Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: A real-life study from the NAVIGATORE Lombardia and Veneto Networks
    Degasperi, Elisabetta
    Spinetti, Angiola
    Lombardi, Andrea
    Landonio, Simona
    Scotton, Pier Giorgio
    Pasulo, Luisa
    Carlotto, Antonio
    Giorgini, Alessia
    Pozzoni, Pietro
    Angeli, Paolo
    Carrara, Maurizio
    Puoti, Massimo
    Gatti, Federico
    Carolo, Giada
    Vinci, Maria
    Zoncada, Alessia
    Bonfanti, Paolo
    Aghemo, Alessio
    Soria, Alessandro
    Centenaro, Riccardo
    Maggiolo, Franco
    Russo, Francesco Paolo
    Rovere, Pierangelo
    Piovesan, Sara
    Capra, Franco
    Viviani, Filippo
    Morini, Lorenzo
    Soffredini, Roberta
    Carriero, Canio
    Paolucci, Stefania
    Noventa, Franco
    Alberti, Alfredo
    Lampertico, Pietro
    Fagiuoli, Stefano
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E217 - E217
  • [27] Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan
    Mushtaq, Saima
    Akhter, Tayyab Saeed
    Khan, Amjad
    Sohail, Aamir
    Khan, Arshad
    Manzoor, Sobia
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [28] Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
    Liu, Chen-Hua
    Peng, Cheng-Yuan
    Liu, Chun-Jen
    Chen, Chi-Yi
    Lo, Ching-Chu
    Tseng, Kuo-Chih
    Su, Pei-Yuan
    Kao, Wei-Yu
    Tsai, Ming-Chang
    Tung, Hung-Da
    Cheng, Hao-Tsai
    Lee, Fu-Jen
    Huang, Chia-Sheng
    Huang, Ke-Jhang
    Shih, Yu-Lueng
    Yang, Sheng-Shun
    Wu, Jo-Hsuan
    Lai, Hsueh-Chou
    Fang, Yu-Jen
    Chen, Po-Yueh
    Hwang, Jow-Jyh
    Tseng, Chi-Wei
    Su, Wei-Wen
    Chang, Chun-Chao
    Lee, Pei-Lun
    Chen, Jyh-Jou
    Chang, Chi-Yang
    Hsieh, Tsai-Yuan
    Chang, Chung-Hsin
    Huang, Yi-Jie
    Kao, Jia-Horng
    HEPATOLOGY INTERNATIONAL, 2023, 17 (02) : 291 - 302
  • [29] Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
    Chen-Hua Liu
    Cheng-Yuan Peng
    Chun-Jen Liu
    Chi-Yi Chen
    Ching-Chu Lo
    Kuo-Chih Tseng
    Pei-Yuan Su
    Wei-Yu Kao
    Ming-Chang Tsai
    Hung-Da Tung
    Hao-Tsai Cheng
    Fu-Jen Lee
    Chia-Sheng Huang
    Ke-Jhang Huang
    Yu-Lueng Shih
    Sheng-Shun Yang
    Jo-Hsuan Wu
    Hsueh-Chou Lai
    Yu-Jen Fang
    Po-Yueh Chen
    Jow-Jyh Hwang
    Chi-Wei Tseng
    Wei-Wen Su
    Chun-Chao Chang
    Pei-Lun Lee
    Jyh-Jou Chen
    Chi-Yang Chang
    Tsai‐Yuan Hsieh
    Chung-Hsin Chang
    Yi-Jie Huang
    Jia-Horng Kao
    Hepatology International, 2023, 17 : 291 - 302
  • [30] Excellent Safety and Sustained Virologic Response to Direct-Acting Antivirals Treatment in HCV-Infected Geriatric Patients: A Real-World Data
    Tung Huynh
    Ke-Qin Hu
    Digestive Diseases and Sciences, 2021, 66 : 1327 - 1334
12345